TGFB1 and chronic kidney disease: Therefore, future studies targeted at exploring potential defects in the activation and signalling pathway of TGF-β might well hold the key to understanding the mechanisms leading to low serum TGF-β isoform levels in CKD patients with atherosclerotic CVD.